facebook
instagram
tiktok
youtube
ENDOVENOUS THERAPY – DR JOSE MENDOZA – www.DoctorJoseMendoza.com

ENGESP

ENDOVENOUS THERAPY

ENDOVENOUS THERAPY

Endovenous Therapy is the administration of liquid substances directly into a vein through an inserted needle or tube (catheter). This allows immediate access to the bloodstream in order to supply fluids and medications.

INFORMATION

The therapeutic, intravenous admistration of Vitamin C is surprisingly common, and has been used to treat scurvy (vitamin C deficiency) for more than 60 years. Recent discoveries have revealed possible mechanisms of action when using intravenous Vitamin C (1). We know that the intravenous route produces therapeutic pharmacological concentrations in the bloodstream, unlike the oral route (2,3). Experiments indicate that it is only in therapeutic concentrations that vitamin C kills cancer cells (4,5,6) and stops tumor growth (7,8).

Intravenous vitamin C is used worldwide in complementary medicine for the treatment of infections, autoimmune diseases, and cancer, as well as in antioxidant therapy (9,10).

Based on the latest evidence, vitamin C is a pro-drug that delivers hydrogen peroxide to the space surrounding cells, thus achieving a protective effect on them. However, if it is administered in high doses (grams) it can cause serious adverse effects in some patients, such as fatigue, irritation, nausea and vomiting.

Vitamin C is finally metabolized into a compound called Oxalate, and can cause further kidney problems in kidney patients (11,12). It induces hemolysis in patients with G6PD deficiency (13,14) and with paroxysmal nocturnal hemoglobinuria (15,16). It remains to be determined whether Vitamin C is safe for the general population.

In order to avoid possible interactions, the doctor who prescribes vitamin C must be aware of the patient’s current medications, whether conventional or complementary.

There are other widely used endovenous therapies, such as the use of Glutathione (an antioxidant), which began to be used in the 90’s, and has a safe use profile. It is potentially useful in reducing the adverse effects of chemotherapy. It is also used as an antiaging agent, in anemia, Alzheimer’s, cancer, diabetes, although its effectiveness hasn’t been clinically proven (16).

Endovenous therapies with these compounds and others can be potentially useful because of their mechanisms of action.

These therapies may be prescribed at the integral medicine appointment.

SERVICE

Start benefiting from intravenous medical therapies. In order to get started, you must complete an initial evaluation in which I take your medical history, conduct a physical examination, and then define what type (s) of therapy would benefit you most. Apart from Vitamin C, there are other types of vitamins, antioxidants, nutrients and special preparations that can recover or enhance your health.

APPOINTMENT

PACKAGE 1

Evaluation Appointment (Face-to-face)
1 Therapy Dose

Regular price:
S/ 280

Offer price:
S/ 250

Card payments

Transfer payments

PACKAGE 2

Evaluation Appointment (Face-to-face)
3 Therapy Dose

Regular price:
S/ 560

Offer price:
S/ 530

Card payments

Transfer payments

CONTACT ME

DR. JOSÉ MENDOZA PAREDES

INTERNAL MEDICINE RESIDENT DOCTOR – UNMSM, ECFMG-USA CERTIFICATE, MASTER IN CLINICAL NUTRITION IN MEDICINE – ESP, MEDICAL CANNABIS – UK, ORTHOMOLECULAR MEDICINE – ESP, PERSONAL TRAINNER – USA, FITNESS-HEALTH COACH.

Schedule your appointment

BIBLIOGRAPHY

ENDOVENOUS THERAPY

  1. Levine M, Espey MG, Chen Q. Losing and finding a way at C: new promise for pharmacologic ascorbate in cancer treatment. Free Radic Biol Med. 2009;47:27–29.
  2. Padayatty SJ, Sun H, Wang Y, Riordan HD, Hewitt SM, Katz A, et al. Vitamin C pharmacokinetics: implications for oral and intravenous use. Ann Intern Med. 2004;140:533–37.
  3. Hoffer LJ, Levine M, Assouline S, Melnychuk D, Padayatty SJ, Rosadiuk K, et al. Phase I clinical trial of i.v. ascorbic acid in advanced malignancy. Ann Oncol. 2008;19:1969–74.
  4. Chen Q, Espey MG, Krishna MC, Mitchell JB, Corpe CP, Buettner GR, et al. Pharmacologic ascorbic acid concentrations selectively kill cancer cells: action as a pro-drug to deliver hydrogen peroxide to tissues. Proc Natl Acad Sci U S A. 2005;102:13604–9.
  5. Chen Q, Espey MG, Sun AY, Lee JH, Krishna MC, Shacter E, et al. Ascorbate in pharmacologic concentrations selectively generates ascorbate radical and hydrogen peroxide in extracellular fluid in vivo. Proc Natl Acad Sci U S A. 2007;104:8749–54.
  6. Chen Q, Espey MG, Sun AY, Pooput C, Kirk KL, Krishna MC, et al. Pharmacologic doses of ascorbate act as a prooxidant and decrease growth of aggressive tumor xenografts in mice. Proc Natl Acad Sci U S A. 2008;105:11105–9
  7. Verrax J, Calderon PB. Pharmacologic concentrations of ascorbate are achieved by parenteral administration and exhibit antitumoral effects. Free Radic Biol Med. 2009;47:27–9
  8. Riordan NH, Riordan HD, Casciari JJ. Clinical and experimental experiences with intravenous vitamin C. J Orthomolecular Med. 2000;15:201–3.
  9. Gonzalez MJ, Miranda-Massari JR, Mora EM, Guzman A, Riordan NH, Riordan HD, et al. Orthomolecular oncology review: ascorbic acid and cancer 25 years later. Integr Cancer Ther. 2005;4:32–44.
  10. Wong K, Thomson C, Bailey RR, McDiarmid S, Gardner J. Acute oxalate nephropathy after a massive intravenous dose of vitamin C. Aust N Z J Med. 1994;24:410–411.
  11. McAllister CJ, Scowden EB, Dewberry FL, Richman A. Renal failure secondary to massive infusion of vitamin C. JAMA. 1984;252:1684
  12. Campbell GD, Jr, Steinberg MH, Bower JD. Ascorbic acid-induced hemolysis in G-6-PD deficiency. Ann Intern Med. 1975;82:810
  13. Rees DC, Kelsey H, Richards JD. Acute haemolysis induced by high dose ascorbic acid in glucose-6- phosphate dehydrogenase deficiency. BMJ. 1993;306:841–42
  14. Iwamoto N, Kawaguchi T, Horikawa K, Nagakura S, Hidaka M, Kagimoto T, et al. Haemolysis induced by ascorbic acid in paroxysmal nocturnal haemoglobinuria. Lancet. 1994;343:357.
  15. Iwamoto N, Nakakuma H, Ota N, Shimokado H, Takatsuki K. Ascorbic acid-induced hemolysis of paroxysmal nocturnal hemoglobinuria erythrocytes. Am J Hematol. 1994;47:337–38.
  16. https://www.webmd.com/vitamins/ai/ingredientmono-717/glutathione